# NexGel, Inc. (NXGL) · Edgar & Edgarette company card

> NexGel (NXGL) grew revenue 31.5% in FY2025 to $11 million, operating margin -29.3% against a 1.2% median for surgical & medical instruments & apparatus, equity 42.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1468929 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/NXGL) · [JSON](https://www.pops4.com/boards/company/NXGL.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $11M |
| Revenue growth, 1 year | 31.5% |
| Revenue growth per year | 64.7% |
| Operating margin | -29.3% (prior year -40.9%) |
| Net margin | -26.3% |
| Operating cash flow | −$1M |
| Capital spending | $68,000 |
| Free cash flow | −$1M |
| Cash | — |
| Long-term debt | $588,000 |
| Total assets | $10M |
| Total equity | $4M |
| Equity ÷ assets | 42.6% |
| Return on equity | -67.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -6.99 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Beneish M: -3.46 (below the −1.78 line)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed late quarterly report notice in the last 12 months; operating cash flow was negative; operating loss: a margin of -29.3% in FY2025; revenue is hard to predict: its 80% range is ±57%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $11.4M (FY2025), total debt $588K. Experience: revenue up 31.5% on the year, up 64.7% a year over 4 years; operating margin -29.3%, up from -40.9%. Soundness: equity 42.6% of assets, return on equity -67.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $9.0M and $33.2M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $8.3M to $36.4M. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -29.3% against a 1.2% median; growth 31.5% against 11.6%.

Range logged 2026-10-08, receipt 7517e97f53e89934, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-04-24 ([filing](https://www.sec.gov/Archives/edgar/data/1468929/000149315226018962/0001493152-26-018962-index.htm))
- Item NT 10-Q Late quarterly report notice: 1, latest 2026-08-17 ([filing](https://www.sec.gov/Archives/edgar/data/1468929/000149315226038553/0001493152-26-038553-index.htm))
- Item 5.02 Director or officer change: 8, latest 2026-11-18 ([filing](https://www.sec.gov/Archives/edgar/data/1468929/000149315226053107/0001493152-26-053107-index.htm))

## Recent filings

- 8-K · filed 2026-11-18 · 5.02 Departure or Election of Directors; Appointment of Officers; 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1468929/000149315226053107/0001493152-26-053107-index.htm)
- 10-Q · filed 2026-11-16 · [filing](https://www.sec.gov/Archives/edgar/data/1468929/000149315226051902/0001493152-26-051902-index.htm)
- 8-K · filed 2026-11-12 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1468929/000149315226051238/0001493152-26-051238-index.htm)
- 8-K · filed 2026-10-07 · 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1468929/000149315226046154/0001493152-26-046154-index.htm)
- 8-K · filed 2026-09-24 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1468929/000149315226044149/0001493152-26-044149-index.htm)
- 8-K · filed 2026-09-23 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1468929/000149315226043955/0001493152-26-043955-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001468929.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1468929

## Cite

POPS4, Edgar & Edgarette: NexGel, Inc. (NXGL) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/NXGL. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

